XML 45 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of fair value of options granted
   Employee 
Expected volatility   95.8%
Expected dividend yield   
-
 
Expected term (in years)   3.01 
Risk-free interest rate   0.46%

 

   Employee 
Expected volatility   92.1%
Expected dividend yield   
-
 
Expected term (in years)   3.5 
Risk-free interest rate   0.17%

 

Schedule of stock option activity
   Number of
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2019   136,489   $27.85    3.9   $
             -
 
Granted   370,397   $1.37    4.9   $
-
 
Exercised   
-
   $
-
    
-
   $
-
 
Forfeited   (10,415)  $
-
    
-
   $
-
 
Expired   
-
   $
-
    
-
   $
-
 
Outstanding at December 31, 2020   496,471   $8.63    3.9   $
-
 
Granted   598,649   $0.97    4.6   $
-
 
Exercised   
-
   $
-
    
-
   $
-
 
Forfeited   (3,300)  $
-
    
-
   $
-
 
Expired   (4,000)  $
-
    
-
   $
-
 
Outstanding at December 31, 2021   1,087,820   $4.08    3.9   $
-
 
Exercisable at December 31, 2021   649,153   $5.38    1.8   $
-
 

 

(1)The aggregate intrinsic value on the table was calculated based on the difference between the estimated fair value of our stock and the exercise price of the underlying option. The estimated stock values used in the calculation was $0.98 and $1.73 per share for each of the years ended December 31, 2021 and 2020, respectively.

 

Schedule of summarizes restricted stock unit activity
   Number of
Units
   Weighted Average
Grant Date Fair Value Per Unit
 
Outstanding as of December 31, 2019   5,877   $30.28 
Granted   30,738(1)  $1.97 
Vested   (4,543)  $1.42 
Forfeited   
-
   $
-
 
Outstanding as of December 31, 2020   32,072   $4.13 
Granted   
-
   $
-
 
Vested   (31,405)  $4.22 
Forfeited   
-
   $
-
 
Outstanding as of December 31, 2021   667   $1.80 

 

(1)30,738 restricted stock units were granted on July 23, 2020 with a weighted average grant date fair value of $1.97.

 

Schedule of stock-based compensation expense
   Years Ended
December 31,
 
   2021   2020 
Research and development  $3   $9 
General and administrative   762    636 
Total stock-based compensation expense  $765   $645